PodcastsTechnologyGet the Check

Get the Check

Anika, Maya, Priya
Get the Check
Latest episode

77 episodes

  • Get the Check

    Elon Musk v. OpenAI, SpaceXAI and Anthropic deal, Cerebras IPO

    05/12/2026 | 38 mins.
    In this episode of Get the Check, the pod breaks down three big stories: the Elon vs. OpenAI trial, SpaceXAI's compute deal with Anthropic, and the Cerebras IPO at a $49B valuation.
    They start with the trial. Greg Brockman's personal journal got subpoenaed and read aloud in court, with entries saying "we weren't honest with [Elon]." Meanwhile, Elon admitted under oath that xAI distilled OpenAI's model, which is a clear violation of OpenAI’s terms & services. The biggest legal hinge is whether GPT-4o qualifies as AGI. Under OpenAI's original nonprofit charter, AGI had to be shared with the world. If it qualifies, Elon has a case. Kalshi odds have been around 50/50 all week (kalshi.com/sign-up?referral=getthecheck), but Maya and Anika both think the judge rules against him.
    Next, the pod gets into the SpaceXAI x Anthropic compute deal. Colossus-1 in Memphis has 300 megawatts of capacity and is running at only 11% utilization (the benchmark for a healthy data center is around 40%). With the SpaceXAI IPO approaching, showing up to public markets with an empty facility would be a red flag, and renting compute to Anthropic is tangible revenue that makes the story look a lot better. The pod also covers SpaceX's moonshot vision of data centers in space. While Maya thinks it’s all PR, Priya was surprised to learn that China already has underwater data centers.
    Then comes the Cerebras IPO. The chip design is impressive: one giant wafer built so an entire model fits on a single chip with no inter-chip communication lag. The challenge is that the models have outgrown it. Cerebras can't run anything above GPT-OSS because it can't support the external memory needs of larger models. They're pricing at a 95x revenue multiple on $510M in 2024 revenue, with a $49B valuation. While revenue is growing a lot YoY, revenue is heavily concentrated in the UAE and OpenAI, which is making many chip plays at once. Priya thinks the $20B OpenAI commitment driving most of the hype faces a real threat in the OpenAI and Broadcom partnership. Tune in to find out if the pod would give Cerebras their check. This weeks’s answer is a hot take.
    This episode is brought to you by
    Kalshi, the prediction market the girls are tracking in real time for Elon's trial odds. Sign up at kalshi.com/sign-up?referral=getthecheck.
    Known, if you’re tired of swiping Known is for you! https://known.com/ is live in SF. Use code GETTHECHECK when you sign up to skip the waitlist.
    Follow the pod on Instagram @getthecheckpod.
    00:00 Intro03:03 Elon Musk v. OpenAI15:11 Elon wants Sam Altman to be hated by America16:01 SpaceXAI x Anthropic Deal17:47 SpaceX IPO18:25 Grok is dead21:30 Do we think Elon will win the case21:58 Cerebras IPO23:34 History of GPUs24:47 Limitations of the Cerebras chip31:59 Cerebras’s revenue concentration35:11 Would Cerebras Get Our Check?
  • Get the Check

    Apple CEO Tim Cook steps down, big tech’s earnings, xAI and Cursor deal

    05/05/2026 | 52 mins.
    In this episode of Get the Check, the pod breaks down a huge week in tech. There’s the historic CEO transition at Apple, a meltdown over Big Tech's capex spend, and xAI’s new plan after Grok was adopted by zero companies we have heard of. Side note, does anyone know why all the big tech companies report on the same day??
    After 15 years of running Apple, Tim Cook is stepping into an Executive Chairman role and giving John Ternus the reigns. The hosts start the segment with Tim Cook's legacy, and there's a lot to unpack. He took Apple from $350M to $4T, invented new categories (shoutout to the AirPod, which Anika insists she hates but has purchased 5 times and counting), and even built a $109B services business that now drives 41% of Apple's profits. They also talk about his misses. The Vision Pro ate 25% of R&D spend for years and was barely even adopted in the heart of SF. Then there’s the elephant in the room, which was no real AI product, even though Siri plus Apple’s personal context set them up perfectly to create consumer AI or some type of assistant. The podcast really needs an assistant, so if John Ternus could work on that the pod is forever indebted. Ternus is a hardware engineer who has worked on every important Apple project since 2001. Maya discusses the real reason she thinks Cook picked him and where he may place important bets.
    Next they get into hyperscaler earnings, and the numbers are genuinely hard to comprehend. Meta, Google, Microsoft, and Amazon collectively announced $700B in data center spending for the year, which is roughly the GDP of most countries. Amazon's free cash flow is down 97%, Meta is burning $370M a day on construction, and the new bottleneck is not GPUs anymore, it is energy. Half of the planned 2026 megawatts are already canceled. The pod also digs into the Sam Altman vs. Sarah Friar drama at OpenAI, which is projected to lose $14B this year as they try to IPO.
    Finally, they get into xAI's proposed deal with Cursor: either a $60B acquisition or a $10B payment for using Colossus, xAI's data center that is sitting at 11% capacity considering Elon’s in the middle of a lawsuit with its otherwise top potential customer OpenAI. Anika's hot take is that this isn’t just a model capabilities problem for Grok it’s also a brand problem - enterprises are not buying Grok after it thought it was Hitler. Priya points out that if this deal closes and Cursor gets locked into Composer only, which is there own model vs. their current approach, which allows users to select between all models then that is a huge opening for anyone else building coding tools.
    This episode is sponsored by Kalshi, the only federally regulated prediction market. Trade on what actually happens in tech, business, and beyond. Sign up at kalshi.com/sign-up?referral=getthecheck.
    Follow the pod on Instagram and X @getthecheckpod. No seriously please we are really trying to grow on X.
    00:00 Our take on the JPM sexual harassment lawsuit
    06:49 Did Tim Cook achieve GOAT status
    09:10 Cook expanding into SaaS12:00 RIP Intel
    14:02 Where Tim Cook got cooked
    14:05 Vision Pro fail17:08 iPhone growth stalls
    19:31 Apple un-intelligence
    27:27 Why Ternus won’t be another Cook
    29:35 What we think Apple will bet on next
    30:40 Hyperscaler capex freakout
    31:35 FCF explained
    45:28 SpaceX Cursor deal
    49:58 Coding tool consolidation50:10 Maya rants about GitHub
  • Get the Check

    Inside the peptide craze: Myra Ahmad (CEO of Mochi Health) and Mansi Hukmani (peptide Substacker) on why everyone is injecting themselves

    04/28/2026 | 1h 8 mins.
    From influencers chasing a deeper tan to AI founders in SF biohacking through their all-nighter before a tier-1 pitch, it feels like everyone is suddenly taking black-market Chinese peptides. And in July, RFK and the FDA may officially reclassify a list of peptides, so that compounding pharmacies can legally sell them again. Startups like Mochi and Superpower are already investing in the supply chain so they can get in on the craze the moment it's legal.
    This week the pod sits down with two of the most knowledgable people in the space. First, Mansi Hukmani, also known as the Chief Longevity Officer, the #1 Substacker writing on peptides and the wellness industrial complex. She gets invited to the bougie loft parties where nurses are injecting hedge fund bros with NAD+ shots between cold plunges, which is exactly the boots on the ground journalism the hosts want.
    Next the trio sits down with Myra Ahmad, founder and CEO of Mochi Health, a marketplace for GLP-1s and primary care providers that has served over 500K patients. Myra has bootstrapped the company to its current size, which is pretty much unheard of in SF. They’ve grown so quickly at a 500% YoY rate that everyone’s taking notice including Eli Lilly who recently sued them over marketing claims. We dive into why Eli Lilly is threatened by a player like Mochi.
    With Mansi the pod gets into:
    Why New York biohackers are different from SF biohackers (and why London is behind)
    How China controls 90% of the global protected amino acid supply, and why HIMS just bought a peptide manufacturer
    Why pharma hates peptides, hint: you can't patent something your body already makes
    The Las Vegas conference where two women fainted on the spot from peptides
    Why Mansi thinks menopause shouldn't exist
    With Myra the hosts unpack:
    How Mochi grew to 500K+ patients
    The 503A vs. 503B compounding pharmacy distinction that the GLP-1 market hinges on
    How HIMS will send you a weight loss medication within 60 seconds of filling out a form, with zero doctor in the loop
    The actual premise of the Eli Lilly lawsuit and why pharma wants compounding to disappear despite centuries of precedence
    Why Mochi invested in a testing lab in San Carlos instead of producing peptides themselves
    If you've ever wondered whether you should try peptides, what's actually in the syringe, or why your group chat suddenly knows what BPC-157 is, the hosts have too, which is why they decided to do this deep dive.
    Thank you to Kalshi for sponsoring: https://kalshi.com/sign-up?referral=getthecheck. Use our referral code to get $10 when you trade! Maybe there will be a market on if Priya takes a peptide in 2026 soon.
    Follow us on Instagram @getthecheckpod and DM us any thoughts on the episode we love hearing from you :)
    00:00 Intro to peptides01:06 Meet Mansi known as Chief Longevity Officer on Substack05:58 Who's actually doing peptides11:43 The peptide players: telehealth companies, pharmacies, pharma, and China13:47 Why peptides are so hard to manufacture16:42 China's chokehold on the supply chain19:49 The big players moving in: HIMS, Superpower, Mochi21:02 Why pharma hates peptides29:44 How the FDA categorizes peptides32:09 Superpower's peptide launch33:44 Should Priya start taking peptides38:40 Psychedelics and why menopause shouldn't exist43:41 Meet Myra, founder and CEO of Mochi Health49:35 The Mochi vs. Eli Lilly lawsuit50:19 What's the point of compounded drugs52:48 The GLP-1 and peptide landscape54:33 Why HIMS doesn't have doctors in the loop56:29 Is pharma evil?57:55 BTS of the FDA classification of peptides1:02:12 Is Mochi selling peptides1:04:19 Why aren’t there clinical trials of major peptides1:07:15 The next billion-dollar peptide will be…1:07:42 Bootstrapping Mochi to 500K patients
  • Get the Check

    Inside BuildForever: Naveen Gavini, Former Pinterest CPO, on Launching Extra and Building for Joy

    04/21/2026 | 57 mins.
    Today the hosts sat down with one of the pioneers of the early 2010s social media era, Naveen Gavini, ex-CPO of Pinterest and one of the company’s first 10 employees. They talk about the rise of social media and what he’s up to now (hint: he’s going back into the consumer tech space).
    If you've ever wondered why people say Pinterest maintained taste vs. Facebook and Instagram, Naveen explains the product decisions that intentionally led to that:
    Ordering the algorithm by saves instead of likes
    Not importing your contacts from Facebook
    Inspiration as a guiding principal over pure engagement
    Naveen was sitting at the dinners in the early 2010s when early Facebook, Instagram, and Twitter employees in Silicon Valley debated the ethics of the algorithm and foresaw the world we now live in, where social media and algorithms are shaping the next generation.
    The hosts ask Naveen what those employees saw coming, what they didn't, and why companies diverged in morals during this time. They also dive into what it was like to help take a company public. Fun fact, Pinterest’s IPO was exactly 7 years before today. Historically IPO access was limited to employees and investors, but now anyone can make money on a private company going public because of Kalshi’s IPO markets. This link gives you $10 when you trade $10: https://kalshi.com/sign-up?referral=getthecheck.
    They also dig into his new company, BuildForever, which is launching Extra, a consumer email product. Email is kind of dead. The hosts can't remember the last time they checked theirs (besides Maya, who's insane and goes through her promos inbox). Extra is rethinking email to be about your personal life and is focused on creating a delightful experience around it.
    They also get into the email application competitive landscape and why Extra is going to fill a gap not addressed by hyper productivity apps like Superhuman or Notion Mail. This is a true consumer product, one that long term can actually be proactive in your inbox, like "we saw you're going to NY, here's a hotel we knew you would like."
    Naveen is offering Get the Check listeners a free code to download the app today, even though it isn't publicly out yet. The first 50 people who download it from the App Store and use code GETTHECHECK become Extra’s first users. Here's the link! If you try it, let us know what you think :)
    00:00 Meet the ex-CPO and 10th employee at Pinterest
    00:27 Being the first person to think Pinterest should be an app
    04:00 What Pinterest did differently than IG and FB
    11:52 Why Pinterest prioritized values over engagement
    14:14 Why you don't notice Pinterest ads
    16:19 From engineer to CPO
    23:55 Saves versus likes on social media
    27:32 Taking a company through IPO
    34:58 Deciding to start a company after every says not to…
    36:27 Email needs a consumer angle
    38:59 Introducing Extra
    47:01 Monetizing in consumer social
  • Get the Check

    Dimitri Knight on Taste in AI and What Designers Do Next

    04/14/2026 | 49 mins.
    Dmitri is a product designer who spent time at Cash App and Ramp, and is now on a deliberate career break — reading, thinking, and figuring out what design means in a world where AI can build the thing but can't decide if it's worth building.
    We discuss:
    - how he taught himself Photoshop at 11 through gaming forums and designed his first bank interface for a video game mod before working in FinTech
    - what taste actually is and why AI can't have it- how the designer role has quietly absorbed six other jobs over the last decade
    - the iconic design choices that shaped how we interact with technology — from Apple and the iPhone to the Nintendo Wii — and why most people never noticed them
    - why great customer service is a design problem that most companies treat as a cost center
    - why the most important design challenges left might have nothing to do with software at all
    00:00 Meet Dmitri
    00:28 Photoshop Origins
    01:48 Design vs Coding
    04:10 Roleplay Mods to UI
    09:30 Dropping Out Reset
    12:53 Apple and Product Design
    16:17 Generalist Designer Era
    17:40 AI Slop and Taste
    21:02 Tasteful vs Distasteful Brands
    23:04 Aesthetics Versus Substance
    24:54 Taste Icons Compared
    26:30 Customer Service Trust
    27:52 AI Commoditizes Software
    29:18 Designing For Meaning
    31:13 Quality Of Life Debate
    34:02 Information And Revolutions
    35:56 Voting And Local Community
    39:31 Design Beyond Software
    40:49 Career Break And Future Plans
    46:03 Gendered Founder Paths
    48:22 Impact Beyond Valuation
More Technology podcasts
About Get the Check
Tune in on Tuesday at 6 AM ET to hear the latest tech news and listen to guests from emerging tech companies.
Podcast website

Listen to Get the Check, The Room Podcast and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features